<!DOCTYPE html><html>  <head>    <meta http-equiv="content-type" content="text/html; charset=UTF-8">    <title>SPHK1</title>  </head>  <body style="     background-color: white; width: 711.299px;">    <p style="background-color: white;"> </p>    <div id="content-protein" class="entry-overview-content" style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px; grid-column: 2 / auto; vertical-align: top; margin-top: 0px; padding-top: 0px; padding-left: 0.5rem; border-left: 4px solid #99c6d7; margin-left: 4px; box-sizing: border-box; color: #222222; font-family: Verdana,Arial,sans-serif; font-size: 13px; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: white; width: 711.806px;">      <h1 property="name" style="font-weight: 700; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px; padding: 0px; font-family: Verdana, sans-serif; line-height: 1.2; margin: 0px; width: auto; font-size: 30px; color: rgb(0, 0, 0); display: inline;">        <span style="color: rgb(0, 0, 0); font-family: Verdana, sans-serif; font-size: 30px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">Sphingosine
          kinase 1</span></h1>    </div>    <p>&nbsp;&nbsp;&nbsp; </p>    <p><span style="font-family: Helvetica,Arial,sans-serif;"><span>0617063 劉懿</span></span></p>    <p><br>    </p>    <p style="text-align: left;"><img src="litemol_screenshot.png" alt="" title="p21_structure"        style="width: 592px; height: 406px;"></p>    <p style="margin-top: -8.88778px; height: 17.1045px;"><b><span style="font-family: Verdana; font-size: 20px; color: #408000;">Motivation</span></b><br>    </p>    <ul>      <li style="background-color: white; width: 743.522px;"> <span style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span            style="color: black;"><font              size="3"><span                style="font-family: &quot;Helvetica Neue&quot;;">The
                reason why I chose SPHK1 was that I found SPHK1 may worsen                bladder cancer </span></font></span></span><span style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span            style="color: black;"><font              size="3"><span                style="font-family: &quot;Helvetica Neue&quot;;"><span                  style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span                    style="color: black;"><font                      size="3"><span                        style="font-family: &quot;Helvetica Neue&quot;;">                        in my project study(Topic: Finding bladder cancer                        related microRNA by GA based on miRNA expression                        profiling and patient clinical data). According to my                        study, hsa-miR-659 is the second informative miRNA in GA                        analysis and SPHK1 is </span></font></span></span></span></font></span></span><span          style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span            style="color: black;"><font              size="3"><span                style="font-family: &quot;Helvetica Neue&quot;;"><span                  style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span                    style="color: black;"><font                      size="3"><span                        style="font-family: &quot;Helvetica Neue&quot;;"><span                          style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span                            style="color: black;"><font                              size="3"><span                                style="font-family: &quot;Helvetica Neue&quot;;">hsa-miR-659
                                target gene</span></font></span></span>, it has                        miRDB target gene score: 83, miRTarBase: strongly                        evidence</span></font></span></span>. Experiment                revealed SPHK1 expression was upregulated in the bladder cancer                and was correlated with histologic gradeand tumor stage.                Patients with high expression of SPHK1 had reduced overall                5-year survival rates(</span></font></span></span><span style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span            style="color: black;"><font              size="3"><span                style="font-family: &quot;Helvetica Neue&quot;;"></span></font></span></span><font          style="font: 12.0px Helvetica; color: #000000"          face="Helvetica"          size="3"          color="#000000">Meng,
          X. D., et al. (2014). "Increased SPHK1 expression is associated with          poor prognosis in bladder cancer." <u>Tumour Biol</u> <b>35</b>(3):          2075-2080.</font><span style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span            style="color: black;"><font              size="3"><span                style="font-family: &quot;Helvetica Neue&quot;;">),
                so I considered if we can find the compound to target SPHK1                binding site may inhibit the tumor cel<span style="color: #222222;"><span                    style="font-family: Verdana,Arial,sans-serif;">l.</span></span></span></font></span></span></li>    </ul>    <img src="file:expression-of-sphk1-in-b.png" alt="" title="ualcansphk1" style="width: 398px; height: 298px;">    <p><br>    </p>    <p><b><span style="font-family: Verdana; font-size: 20px; color: #408000;"><span            style="color: #ff6666;">Function</span><br>        </span></b> </p>    <ul>      <li style="width: 743.776px;"><span style="font-family: Helvetica,Arial,sans-serif;"><span            property="text"            style="font-weight: 400; font-style: Helvetica Neue; text-decoration: none; text-align: left; text-indent: 0px;">Has
            a negative effect on intracellular ceramide levels, enhances cell            growth and inhibits apoptosis. </span></span><span style="font-family: Helvetica,Arial,sans-serif;"><span            property="text"            style="font-weight: 400; font-style: Helvetica Neue; text-decoration: none; text-align: left; text-indent: 0px;">Involved
            in the regulation of inflammatory response and neuroinflammation.            Via the product sphingosine 1-phosphate, stimulates TRAF2 E3            ubiquitin ligase activity, and promotes activation of NF-kappa-B in            response to TNF signaling leading to IL17 secretion. In response to            TNF and in parallel to NF-kappa-B activation, negatively regulates            RANTES induction through p38 MAPK signaling pathway. Involved in            endocytic membrane trafficking induced by sphingosine, recruited to            dilate endosomes, also plays a role on later stages of endosomal            maturation and membrane fusion independently of its kinase activity.            In Purkinje cells, seems to be also involved in the regulation of            autophagosome-lysosome fusion upon VEGFA. Has serine            acetyltransferase activity on PTGS2/COX2 in an acetyl-CoA dependent            manner. The acetyltransferase activity increases in presence of the            kinase substrate, sphingosine. During neuroinflammation, through            PTGS2 acetylation, promotes neuronal secretion of specialized            preresolving mediators (SPMs), especially 15-R-lipoxin A4, which            results in an increase of phagocytic microglia</span><span style="color: #222222; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">.</span></span></li>      <li style="width: 743.776px;"><span style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, stixgeneral, serif; font-size: 15.999099731445313px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration: none; display: inline !important; float: none;">Sphingosine
          kinase (SphK) is a lipid enzyme that maintains cellular lipid          homeostasis. </span><br>        <span style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, stixgeneral, serif; font-size: 15.999099731445313px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration: none; display: inline !important; float: none;"><span            style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, stixgeneral, serif; font-size: 15.999099731445313px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration: none; display: inline !important; float: none;">Historically,<span              class="Apple-converted-space">            </span></span>SphK1 is mainly associated with oncogenicity, however          in reality, both SphK1 and SphK2 isozymes possess oncogenic properties          and are recognized therapeutic targets. The absence of mutations of          SphK in various cancer types has led to the theory that cancer cells          develop a dependency on SphK signaling (hyper-SphK signaling) or          “non-oncogenic addiction”.(</span><span style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, stixgeneral, serif; font-size: 15.999099731445313px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration: none; display: inline !important; float: none;"><span            style="caret-color: rgb(48, 48, 48); color: rgb(48, 48, 48); font-family: arial, helvetica, clean, sans-serif; font-size: 13px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration: none; display: inline !important; float: none;">Haddadi,
            Nahal et al. “"Dicing and Splicing" Sphingosine Kinase and Relevance            to Cancer.”<span class="Apple-converted-space">&nbsp;</span></span><i            style="caret-color: rgb(48, 48, 48); color: rgb(48, 48, 48); font-family: arial, helvetica, clean, sans-serif; font-size: 13px; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none;">International
            journal of molecular sciences</i><span style="caret-color: rgb(48, 48, 48); color: rgb(48, 48, 48); font-family: arial, helvetica, clean, sans-serif; font-size: 13px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration: none; display: inline !important; float: none;"><span              class="Apple-converted-space">&nbsp;</span>vol.
            18,9 1891. 2 Sep. 2017</span>)<br>        </span></li>    </ul>    <p><br>    </p>    <p> <span style="color: #8c6eb7; font-size: 20px; font-family: Verdana"><b>          STITCH: Chemical–Protein Interactions</b></span></p>    <p><br>    </p>    <p style="background-color: white;"> <img src="sphk1stit.png" alt="" title="sphk1_stitch"        style="width: 529.94px;"        width="45%"></p>    <p> <span style="color: #8c6eb7; font-size: 20px"><b><span style="font-family: Verdana; color: #004080;">Sequence</span><br>        </b></span></p>    <p style="background-color: white;"> </p>    <div style="text-align: left;">      <pre class="sequence" style="font-weight: 400; font-style: normal; text-decoration: none; text-indent: 0px; font-family: monospace,monospace; font-size: 14.04px; white-space: pre-wrap; overflow-wrap: break-word; padding: 29.5417px; border-width: 0px; border-style: dotted; overflow: auto; color: #222222; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: white; width: 1008.18px;">        10         20         30         40         50<brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">MDPAGGPRGV LPRPCRVLVL LNPRGGKGKA LQLFRSHVQP LLAEAEISFT <brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">        60         70         80         90        100<brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">LMLTERRNHA RELVRSEELG RWDALVVMSG DGLMHEVVNG LMERPDWETA <brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       110        120        130        140        150<brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">IQKPLCSLPA GSGNALAASL NHYAGYEQVT NEDLLTNCTL LLCRRLLSPM <brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       160        170        180        190        200<brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">NLLSLHTASG LRLFSVLSLA WGFIADVDLE SEKYRRLGEM RFTLGTFLRL <brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       210        220        230        240        250<brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">AALRTYRGRL AYLPVGRVGS KTPASPVVVQ QGPVDAHLVP LEEPVPSHWT <brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       260        270        280        290        300<brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">VVPDEDFVLV LALLHSHLGS EMFAAPMGRC AAGVMHLFYV RAGVSRAMLL <brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       310        320        330        340        350<brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">RLFLAMEKGR HMEYECPYLV YVPVVAFRLE PKDGKGVFAV DGELMVSEAV <brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       360        370        380 <brstyle="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">QGQVHPNYFW MVSGCVEPPP SWKPQQMPPP EEPL        </pre>    </div>    <p style="background-color: white;"> </p>    <p style="background-color: white;"></p>  </body></html>